| JXSL1000021 | Insulin Degludec/Insulin Aspart注射液 | insulin aspart;insulin degludec | Injection | Biological Products | Import Drug Application | 2010-05-21 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | Certificate Issued | 2011-04-28 | view |
| JXSR1100001 | Insulin Degludec/Insulin Aspart注射液 | insulin aspart;insulin degludec | Injection | Biological Products | State Standards | 2011-07-21 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | Certificate Issued | 2012-11-06 | view |
| AS19990011 | 重组人门冬胰岛素注射液 | | Injection | Biological Products | Import Drug Application | 2000-01-01 | 诺和诺德（天津）生物技术有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Approval Completed-Pending Certificated | 2002-08-16 | view |
| CXSL1400032 | 重组门冬胰岛素注射液 | | Injection | Biological Products(15) | New Drug Application | 2014-05-30 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXSL2101313 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2021-09-08 | | ChongQing Chenan Biopharmaceutical Co Ltd | | | view |
| JYSB1900216 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2019-08-27 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2019-08-26 | view |
| CXSL1500063 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2015-09-09 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | Certificate Issued | 2017-04-07 | view |
| JYSB0900056 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2009-03-26 | 丹麦诺和诺德公司 | Novo Nordisk A/S;Novo Nordisk Pharmaceutical Industries Inc | Certificate Issued | 2010-08-19 | view |
| CYSB2101304 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-12-23 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2000186 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2020-05-13 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-05-19 | view |
| CXSS1700029 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
| CXSL2400058 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2024-01-25 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CYSB2101177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-09-06 | | Gan & Lee Pharmaceuticals | | | view |
| CXSS2100025 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2021-02-26 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | In Review | 2021-02-25 | view |
| JYSZ1900008 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | License Renew | 2019-03-08 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2019-11-25 | view |
| CYSB2500062 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL1200103 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2013-02-19 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2015-01-07 | view |
| JYSB0700030 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2007-03-02 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2008-04-22 | view |
| CYSB2200228 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| JYSB1900312 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2019-11-14 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2019-11-21 | view |
